HALOZYME THERAPEUTICS INC (HALO) Stock Balance Sheet
NASDAQ:HALO • US40637H1095
Current stock price
67.82 USD
+0.74 (+1.1%)
At close:
67.82 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 133.82M | 115.85M | 118.37M | 234.20M | 118.70M | |||
| Marketable Securities | 9.00M | 480.22M | 217.63M | 128.60M | 622.20M | |||
| Receivables | 441.27M | 308.45M | 234.21M | 231.10M | 91.00M | |||
| Inventories | 176.47M | 141.86M | 127.60M | 100.10M | 53.90M | |||
| Other Current Assets | 64.64M | 38.95M | 48.61M | 45.00M | 40.50M | |||
| Total Current Assets | 825.21M | 1.09B | 746.42M | 739.00M | 926.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 82.14M | 75.03M | 74.94M | 75.60M | 8.80M | |||
| Goodwill | 580.36M | 416.82M | 416.82M | 409.00M | N/A | |||
| Intangibles | 981.47M | 401.83M | 472.88M | 546.70M | N/A | |||
| Other Non-Current Assets | 56.15M | 84.45M | 22.20M | 71.20M | 169.30M | |||
| Total Non-Current Assets | 1.70B | 978.14M | 986.85M | 1.10B | 178.10M | |||
| TOTAL ASSETS | 2.53B | 2.06B | 1.73B | 1.84B | 1.10B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 13.30M | 89.40M | |||
| Accrued Expenses | 156.19M | 128.85M | 99.72M | 96.50M | 24.40M | |||
| Accounts Payable | 20.90M | 10.25M | 11.82M | 17.70M | 1.50M | |||
| Other Current Liabilities | N/A | N/A | 963.00K | 3.20M | 1.70M | |||
| Total Current Liabilities | 177.09M | 139.10M | 112.49M | 130.80M | 117.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.14B | 1.51B | 1.50B | 1.49B | 787.30M | |||
| Deferred Taxes/Income | 42.92M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 113.86M | 54.76M | 37.72M | 48.20M | 3.10M | |||
| Total Non-Current Liabilities | 2.30B | 1.56B | 1.54B | 1.54B | 790.40M | |||
| TOTAL LIABILITIES | 2.48B | 1.70B | 1.65B | 1.67B | 907.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 54.79M | 359.87M | 90.55M | 143.20M | -58.90M | |||
| Additional Paid In Capital | 12.00M | 0.00 | 2.41M | 27.40M | 256.30M | |||
| Common Shares | 118.00K | 123.00K | 127.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -18.09M | 3.83M | -9.28M | -900.00K | -600.00K | |||
| Shares Outstanding | 117.78M | 123.14M | 126.77M | 135.20M | 137.50M | |||
| Tangible Book Value per Share | -12.85 | -3.69 | -6.36 | -5.81 | 1.43 | |||
| Total Shareholders' Equity | 48.81M | 363.82M | 83.81M | 169.80M | 197.00M | |||
| TOTAL LIABILITIES AND EQUITY | 2.53B | 2.06B | 1.73B | 1.84B | 1.10B | |||
| Statistics | ||||||||
| Debt/Equity | 43.89 | 4.14 | 17.89 | 8.79 | 4.00 | |||
| Current Ratio | 4.66 | 7.80 | 6.64 | 5.65 | 7.91 | |||
| Return On Assets (ROA) | 12.55% | 21.52% | 16.25% | 10.97% | 36.46% | |||
| Return On Equity (ROE) | 649.18% | 122.06% | 336.00% | 119.02% | 204.42% | |||
| Return On Invested Capital (ROIC) | 25.65% | 21.15% | 15.48% | 12.48% | 20.62% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 27.31% | 30.64% | 19.53% | 15.84% | 82.63% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 93.59% | 79.85% | 63.52% | 54.45% | 82.63% | |||
All data in USD , ROIC based on taxRate of 0.26